Dartmouth College School of Medicine, Lebanon
Multiple primary melanoma risk linked to atypical moles
Published in Cancer Law Weekly, June 10th, 2006
According to a recent article published in the journal Archives of Dermatology, scientists in the United States conducted a study "to assess the frequency of occurrence and risk factors for multiple primary melanoma [via a] population-based, case-control study."
"Three-hundred fifty-four New Hampshire residents with a confirmed first diagnosis of cutaneous melanoma [were studied]," explained L. Titusernstoff and colleagues, Dartmouth College School of Medicine. "An additional melanoma...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2006-06-10)
More Articles from Cancer Law Weekly
- Adventrx Pharmaceuticals, Inc.
Adventrx closes merger with SD Pharmaceuticals - British Columbia Cancer Agency
Researchers' work from British Columbia Cancer Agency adds to body of knowledge - Oxigene, Inc.
U.S. patent granted for Oxigene's therapeutic candidate for oncology, Combretastatin A4P - Philanthropy
New York City-based LegalHealth provides free legal counsel for cancer survivors - University of Wisconsin
Researchers' work from University of Wisconsin adds to body of knowledge - AMDL, Inc.
AMDL notified by AMEX of the need to satisfy continued listing standards - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
